Dr. Chagpar on Contralateral Prophylactic Mastectomy
Anees B. Chagpar, MD, MPH, MBA, Yale Comprehensive Cancer Center, discusses contralateral prophylactic mastectomy for patients with breast cancer.
Chagpar says the number of patients who would like this procedure has been increasing, possibly because it provides patients with peace of mind. Patients who are young, have a family history or a genetic predisposition for breast cancer may choose to have a contralateral prophylactic mastectomy to prevent recurrences.
The procedure is associated with high levels of patient satisfaction; however, there is an increase in cost for the technical portion and hospital stay, as well as complications. While some say that there is not a survival benefit for this procedure, recent data suggests that young patients with low-stage breast cancer could benefit.
Anees B. Chagpar, MD, MPH, MBA, associate professor of surgery (oncology), director, The Breast Center at Smilow Cancer Hospital at Yale-New Haven, assistant director, Global Oncology, Yale Comprehensive Cancer Center, discusses contralateral prophylactic mastectomy for patients with breast cancer.
Batalini Explores Role of UGT1A1 in Patients Treated With Sacituzumab Govitecan for HR+ MBC
April 22nd 2024During a Community Case Forum live event in partnership with The Arizona Clinical Oncology Society, Felipe Batalini, MD, discussed the TROPiCS-02 trial of sacituzumab govitecan and the impact of the UGT1A1 status on adverse event frequency.
Read More
Breast Cancer Leans into the Decade of Antibody-Drug Conjugates, Experts Discuss
September 25th 2020In season 1, episode 3 of Targeted Talks, the importance of precision medicine in breast cancer, and how that vitally differs in community oncology compared with academic settings, is the topic of discussion.
Listen
